Development of a sensitive and specific serological assay based on luminex technology for detection of antibodies to Zaire Ebola virus

Journal of Clinical Microbiology

Volumn 55, Issue 1, 2017, Pages 165-176

  Ayouba, Ahidjo ^a   Touré, Abdoulaye ^b   Butel, Christelle ^a   Keita, Alpha Kabinet ^a   Binetruy, Florian ^a   Sow, Mamadou S ^c   Foulongne, Vincent ^d   Delaporte, Eric ^a   Peeters, Martine ^a   Baize, Sylvain ^e   Bangoura, Kaba ^e   Barry, Alimou ^e   Barry, Moumié ^e   Cissé, Mohammed ^e   Delfraissy, Jean François ^e   Delmas, Christelle ^e   Desclaux, Alice ^e   Diallo, Saliou Bella ^e   Diallo, Mamadou Safiatou ^e   Diallo, Mariama Sadio ^e   Étard, Jean François ^e   Etienne, Cécile ^e   Faye, Ousmane ^e   Fofana, Ibrahima ^e   Granouillac, Bruno ^e   Hébert, Esther Hereth ^e   Izard, Suzanne ^e   Kassé, Djenaba ^e   Koivogui, Lamine ^e   Kpamou, Cécé ^e   Lacarabaratz, Christine ^e   Leroy, Sandrine ^e   Marchal, Claire Levy ^e   Lévy, Yves ^e   Mendiboure, Vincent ^e   Magassouba, N'Fally ^e   March, Laura ^e   Msellati, Philippe ^e   Niane, Harissatou ^e   Pers, Yves Marie ^e   Raoul, Hervé ^e   Sacko, Sidi Lamine ^e   Savané, Ibrahima ^e   Sow, Mamadou Saliou ^e   Taverne, Bernard ^e   Traoré, Fodé Amara ^e   Yazdanpanah, Yazdan ^e   more..

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b Guinée Centre de Recherche et de Formation en Infectiologie de Guinée Guinean infectiology research and training center   (Guinea)

^c Donka National Hospital   (Guinea)

^d UMR 1058 University of Montpellier   (France)

^e NONE

Author keywords

Ebola virus; Luminex; Recombinant proteins; Serology

Indexed keywords

GLYCOPROTEIN; NUCLEOPROTEIN; PROTEIN VP40; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ARTICLE; BUNDIBUGYO EBOLA VIRUS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSS REACTION; ELISA KIT; EPIDEMIC; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT REPEATABILITY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PERFORMANCE; PREDICTIVE VALUE; PRIORITY JOURNAL; RESTON EBOLA VIRUS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEROLOGY TEST KIT; SUDAN EBOLA VIRUS; VIRUS DETECTION; VIRUS STRAIN; VIRUS TITRATION; ZAIRE EBOLAVIRUS; AFRICA; BLOOD; EBOLAVIRUS; EVALUATION STUDY; FRANCE; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; PROCEDURES;

AFRICA; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CROSS REACTIONS; EBOLAVIRUS; FRANCE; HEMORRHAGIC FEVER, EBOLA; HUMANS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 85008323947     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01979-16     Document Type: Article

References (32)

1. Pigott DM, Golding N. 2014. Mapping the zoonotic niche of Ebola virus disease in Africa. Elife 3:e04395.
2. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traore A, Kolie M, Malano ER, Heleze E, Bocquin A, Mely S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Gunther S. 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371: 1418-1425. https://doi.org/10.1056/NEJMoa1404505.
3. WHO. 2016. Ebola situation reports. WHO, Geneva, Switzerland. http://apps.who.int/ebola/ebola-situation-reports. Accessed 23 September 2016.
4. Baize S. 2015. Ebola virus in West Africa: new conquered territories and new risks - or how I learned to stop worrying and (not) love Ebola virus. Curr Opin Virol 10:70-76. https://doi.org/10.1016/j.coviro.2015.01.008.
5. Pigott DM, Millear AI, Earl L, Morozoff C. 2016. Updates to the zoonotic niche map of Ebola virus disease in Africa. Elife 5:e16412.
6. Ogawa H, Miyamoto H, Nakayama E, Yoshida R, Nakamura I, Sawa H, Ishii A, Thomas Y, Nakagawa E, Matsuno K, Kajihara M, Maruyama J, Nao N, Muramatsu M, Kuroda M, Simulundu E, Changula K, Hang'ombe B, Namangala B, Nambota A, Katampi J, Igarashi M, Ito K, Feldmann H, Sugimoto C, Moonga L, Mweene A, Takada A. 2015. Seroepidemiological prevalence of multiple species of filoviruses in fruit bats (Eidolon helvum) migrating in Africa. J Infect Dis 212(Suppl 2):S101-S108.
7. Bermejo M, Rodriguez-Teijeiro JD, Illera G, Barroso A, Vila C, Walsh PD. 2006. Ebola outbreak killed 5000 gorillas. Science 314:1564. https://doi.org/10.1126/science.1133105.
8. Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, Froment JM, Bermejo M, Smit S, Karesh W, Swanepoel R, Zaki SR, Rollin PE. 2004. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303:387-390. https://doi.org/10.1126/science.1092528.
9. Colebunders R, Van den Ende J. 2015. Filovirus epidemic in 1956 in Bili, DRC. Lancet Infect Dis 15:379. https://doi.org/10.1016/S1473-3099(15)70092-7.
10. Mulangu S, Borchert M, Paweska J, Tshomba A, Afounde A, Kulidri A, Swanepoel R, Muyembe-Tamfum JJ, Van der Stuyft P. 2016. High prevalence of IgG antibodies to Ebola virus in the Efe pygmy population in the Watsa region, Democratic Republic of the Congo. BMC Infect Dis 16:263. https://doi.org/10.1186/s12879-016-1607-y.
11. Broadhurst MJ, Brooks TJ, Pollock NR. 2016. Diagnosis of Ebola virus disease: past, present, and future. Clin Microbiol Rev 29:773-793. https://doi.org/10.1128/CMR.00003-16.
12. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. 1999. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 179(Suppl 1): S192-S198.
13. Krähling V, Becker D, Rohde C, Eickmann M, Eroglu Y, Herwig A, Kerber R, Kowalski K, Vergara-Alert J, Becker S. 2016. Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med Microbiol Immunol 205:173-183. https://doi.org/10.1007/s00430-015-0438-6.
14. Becquart P, Mahlakoiv T, Nkoghe D, Leroy EM. 2014. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus. PLoS One 9:e96360. https://doi.org/10.1371/journal.pone.0096360.
15. Saijo M, Niikura M, Morikawa S, Ksiazek TG, Meyer RF, Peters CJ, Kurane I. 2001. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol 39:1-7. https://doi.org/10.1128/JCM.39.1.1-7.2001.
16. Huang Y, Zhu Y, Yang M, Zhang Z, Song D, Yuan Z. 2014. Nucleoproteinbased indirect enzyme-linked immunosorbent assay (indirect ELISA) for detecting antibodies specific to Ebola virus and Marbug virus. Virol Sin 29:372-380. https://doi.org/10.1007/s12250-014-3512-0.
17. Becquart P, Wauquier N, Mahlakoiv T, Nkoghe D, Padilla C, Souris M, Ollomo B, Gonzalez JP, De Lamballerie X, Kazanji M, Leroy EM. 2010. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 5:e9126. https://doi.org/10.1371/journal.pone.0009126.
18. Moyen N, Thirion L, Emmerich P, Dzia-Lepfoundzou A, Richet H, Boehmann Y, Dimi Y, Gallian P, Gould EA, Gunther S, de Lamballerie X. 2015. Risk factors associated with Ebola and Marburg viruses seroprevalence in blood donors in the Republic of Congo. PLoS Negl Trop Dis 9:e0003833. https://doi.org/10.1371/journal.pntd.0003833.
19. Bernhard OK, Mathias RA, Barnes TW, Simpson RJ. 2011. A fluorescent microsphere-based method for assay of multiple analytes in plasma. Methods Mol Biol 728:195-206. https://doi.org/10.1007/978-1-61779-068-3-12.
20. Ahuka-Mundeke S, Ayouba A, Mbala-Kingebeni P, Liegeois F, Esteban A, Lunguya-Metila O, Demba D, Bilulu G, Mbenzo-Abokome V, Inogwabini BI, Muyembe-Tamfum JJ, Delaporte E, Peeters M. 2011. Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay. Emerg Infect Dis 17:2277-2286. https://doi.org/10.3201/eid1712.110783.
21. Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debre P, Fisher-Hoch SP, McCormick JB, Georges AJ. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 5:423-426. https://doi.org/10.1038/7422.
22. Biggar RJ, Melbye M, Kestens L, de Feyter M, Saxinger C, Bodner AJ, Paluko L, Blattner WA, Gigase PL. 1985. Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire. Br Med J (Clin Res Ed) 290:808-810. https://doi.org/10.1136/bmj.290.6471.808.
23. de The G, Gessain A, Gazzolo L, Robert-Guroff M, Najberg G, Calender A, Peti M, Brubaker G, Bensliman A, Fabry F, Strobel M, Robin Y, Fortune R. 1985. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res 45: 4633s-4636s.
24. Wendler I, Schneider J, Gras B, Fleming AF, Hunsmann G, Schmitz H. 1986. Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) 293:782-785. https://doi.org/10.1136/bmj.293.6550.782.
25. Ewer K, Rampling T, Venkatraman N, Bowyer G, Wright D, Lambe T, Imoukhuede EB, Payne R, Fehling SK, Strecker T, Biedenkopf N, Krahling V, Tully CM, Edwards NJ, Bentley EM, Samuel D, Labbe G, Jin J, Gibani M, Minhinnick A, Wilkie M, Poulton I, Lella N, Roberts R, Hartnell F, Bliss C, Sierra-Davidson K, Powlson J, Berrie E, Tedder R, Roman F, De Ryck I, Nicosia A, Sullivan NJ, Stanley DA, Mbaya OT, Ledgerwood JE, Schwartz RM, Siani L, Colloca S, Folgori A, Di Msarco S, Cortese R, Wright E, Becker S, Graham BS, Koup RA, Levine MM, Volkmann A, Chaplin P, Pollard AJ, Draper SJ, Ballou WR, Lawrie A, Gilbert SC, Hill AV. 2016. A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA. N Engl J Med 374:1635-1646. https://doi.org/10.1056/NEJMoa1411627.
26. Komatsu N, Shichijo S, Nakagawa M, Itoh K. 2004. New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Lab Invest 64:535-545. https://doi.org/10.1080/00365510410007008.
27. Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, Lutwama JJ, Lobel L, Dye JM, Ulrich RG. 22 June 2016. Human survivors of disease outbreaks caused by Ebola or Marburg viruses exhibit crossreactive and long-lived antibody responses. Clin Vaccine Immunol https://doi.org/10.1128/cvi.00107-16.
28. Sobarzo A, Ochayon DE, Lutwama JJ, Balinandi S, Guttman O, Marks RS, Kuehne AI, Dye JM, Yavelsky V, Lewis EC, Lobel L. 2013. Persistent immune responses after Ebola virus infection. N Engl J Med 369: 492-493. https://doi.org/10.1056/NEJMc1300266.
29. Rimoin A, Mukadi WP, Doshi R, Hoff N, Bramble M, Alfonso V, Mwanza A, Mukadi D, Nicholson B, Kebela B, Okitolonda E, Lu K, Steffen I, Olinger G, Hensley L, Simmons G, Muyembe-Tamfum JJ. 2016. Persistent immune response in Ebola survivors from Yambuku outbreak 40 years after infection, abstr 5. 8th International Symposium on Filoviruses, Antwerp, Belgium, 12 to 15 September 2016.
30. Sow MS, Etard JF, Baize S, Magassouba N, Faye O, Msellati P, Toure AI, Savane I, Barry M, Delaporte E. 3 May 2016. New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors. J Infect Dis https://doi.org/10.1093/infdis/jiw078.
31. Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toure-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M. 2014. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia. J Clin Microbiol 52: 578-586. https://doi.org/10.1128/JCM.02860-13.
32. Wilson EB. 1927. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22:209-212.